Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1974 1
1975 2
1978 1
1979 2
1983 2
1984 9
1985 3
1986 1
1987 5
1988 6
1989 8
1990 6
1991 5
1992 9
1993 8
1994 16
1995 10
1996 10
1997 8
1998 13
1999 14
2000 13
2001 13
2002 9
2003 10
2004 11
2005 7
2006 3
2007 5
2008 10
2009 7
2010 12
2011 8
2012 15
2013 15
2014 7
2015 9
2016 10
2017 8
2018 16
2019 7
2020 10
2021 4
2022 7
2023 7
2024 10
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

363 results

Results by year

Filters applied: . Clear all
Page 1
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis.
Fox RJ, Bar-Or A, Traboulsee A, Oreja-Guevara C, Giovannoni G, Vermersch P, Syed S, Li Y, Vargas WS, Turner TJ, Wallstroem E, Reich DS; HERCULES Trial Group. Fox RJ, et al. N Engl J Med. 2025 May 15;392(19):1883-1892. doi: 10.1056/NEJMoa2415988. Epub 2025 Apr 8. N Engl J Med. 2025. PMID: 40202696 Clinical Trial.
A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P; FREEDOMS Study Group. Kappos L, et al. N Engl J Med. 2010 Feb 4;362(5):387-401. doi: 10.1056/NEJMoa0909494. Epub 2010 Jan 20. N Engl J Med. 2010. PMID: 20089952 Free article. Clinical Trial.
Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis.
Oh J, Arnold DL, Cree BAC, Ionete C, Kim HJ, Sormani MP, Syed S, Chen Y, Maxwell CR, Benoit P, Turner TJ, Wallstroem E, Wiendl H; Tolebrutinib Phase 3 GEMINI 1 and 2 Trial Group. Oh J, et al. N Engl J Med. 2025 May 15;392(19):1893-1904. doi: 10.1056/NEJMoa2415985. Epub 2025 Apr 8. N Engl J Med. 2025. PMID: 40202623 Clinical Trial.
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.
Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D; evolutionRMS investigators. Montalban X, et al. Lancet Neurol. 2024 Nov;23(11):1119-1132. doi: 10.1016/S1474-4422(24)00328-4. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307151 Clinical Trial.
Mitochondria and ageing.
Cottrell DA, Turnbull DM. Cottrell DA, et al. Curr Opin Clin Nutr Metab Care. 2000 Nov;3(6):473-8. doi: 10.1097/00075197-200011000-00009. Curr Opin Clin Nutr Metab Care. 2000. PMID: 11085833 Review.
Self directed learning.
Towle A, Cottrell D. Towle A, et al. Among authors: cottrell d. Arch Dis Child. 1996 Apr;74(4):357-9. doi: 10.1136/adc.74.4.357. Arch Dis Child. 1996. PMID: 8669942 Free PMC article. Review.
Sodium-glucose cotransporter-2 inhibitor prescribing practices.
Alcorn C, Subarajan P, Kesari A, Lockhart M, Cottrell D, Jordan K. Alcorn C, et al. Among authors: cottrell d. Diabetes Obes Metab. 2023 Apr;25(4):1136-1139. doi: 10.1111/dom.14931. Epub 2022 Dec 21. Diabetes Obes Metab. 2023. PMID: 36478138 No abstract available.
Key information about moyamoya.
Cottrell DB, Haley SM. Cottrell DB, et al. Nursing. 2024 Oct 1;54(10):12-14. doi: 10.1097/NSG.0000000000000077. Epub 2024 Sep 20. Nursing. 2024. PMID: 39302744 No abstract available.
363 results